Navigation Links
Beckman Coulter Announces Third Quarter 2007 Results
Date:10/30/2007

ed, these items have been excluded in the "Adjusted Results" presentation of our operating results herein. These non-GAAP disclosures are as follows:

a) Supply Chain Relocation -- In January 2007, as part of the company's

previously announced strategic supply chain management initiative, the

company announced the closure of its manufacturing site in Palo Alto,

California and the relocation of those operations to Indianapolis,

Indiana. In connection with this closure and relocation, the company

recorded charges related to severance and other costs of $6.9 million

in the first quarter of 2007. In addition, during the quarter ended

June 30, 2007, the company announced the closure and relocation of

other manufacturing and distribution sites, mainly in the United

States. Total supply chain relocation charges for the three and nine

months ended September 30, 2007 were $3.0 million and $12.7 million,

respectively. Also, during the second quarter of 2007 the company

recorded related asset impairment charges of $0.8 million.

b) Miami Vacant Land Sale -- On July 30, 2007, the company sold vacant

land adjacent to its Miami, Florida facility for $30.0 million. An

additional $1.2 million remains in escrow for a portion of the land for

which title is in dispute. The company acquired the parcel of vacant

land as part of its 1997 acquisition of Coulter Corporation. The gain

on sale of $26.2 million was recorded in other non-operating income

during the quarter ended September 30, 2007.

c) Beckman Coulter Foundation -- Using proceeds from the Miami vacant land

sale the company made a $9 million contribution to establish and fund

the Beckman Coulter Foundation (the "Foundation"), during the quarter

ended September 30, 2007. The purpose of this non-profit Foundation is


'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... September 17, 2014 ... action from a truly novel class of ... MGB Biopharma, a biopharmaceutical company developing a ... that it has secured £4.0m ($6.4m) to ... MGB-BP-3, against a range of Gram-positive infections ...
(Date:9/17/2014)... The Alliance for Clinical Research ... collaborative building a global system to enhance safety, ... Phase 3 of its Site Accreditation and Standards ... Kalali, Vice-President, Global Head, Neuroscience Center of Excellence ... Quality Integration (CQI) Consulting will lead the effort ...
(Date:9/16/2014)... chin strap that can harvest energy from jaw movements ... Canada. , It is hoped that the device can ... a number of small-scale implantable or wearable electronic devices, ... and communication devices. , The first results of the ... IOP Publishing,s journal Smart Materials and Structures . ...
(Date:9/16/2014)... cars and flashlights, batteries play an important role ... are seeking ways to improve battery life and ... water-based solution, researchers at the University of Missouri ... battery that could be used for many applications ... and also in complicated applications such as space ...
Breaking Biology Technology:MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 2MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 3MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 4MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 5MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 6MGB Biopharma Secures £4.0m ($6.4m) to Advance its Novel Lead Antibacterial, MGB-BP-3, into Clinical Development 7Global Standards Initiative for Clinical Research Sites Advances 2Global Standards Initiative for Clinical Research Sites Advances 3Global Standards Initiative for Clinical Research Sites Advances 4'Smart material' chin strap harvests energy from chewing 2
... 25 Scimitar Equity, LLC issues a ... VOQP), entitled,"Creating Value; Turnaround Leverages Product Opportunities ... review is available at website: http://www.scimitarequity.com ... Jersey-based biotechnology company,dedicated to becoming a recognized ...
... 25 Mymetics,Corporation (OTC: MYMX), will be holding an ... PM New York Time to update all shareholders,on the ... Form 10-Q and to,address recent press articles., You ... at +1-866-591-4361 PIN 815,726 and from Europe at +41-800-329-326 ...
... 23 Eisai Corporation of,North America and its ... Food and Drug Administration (FDA) has approved a ... prevention of,chemotherapy-induced nausea and vomiting (CINV). ALOXI Capsules ... prevention of acute nausea and,vomiting following initial and ...
Cached Biology Technology:VioQuest Pharmaceuticals, Inc Q2/08 Review Issued by Scimitar Equity, LLC 2FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting 2FDA Approves ALOXI(R) (Palonosetron HCl) Capsules for Prevention of Acute Chemotherapy-induced Nausea and Vomiting 3
(Date:9/16/2014)... The 36 Pit Fire began on September 13, 2014. ... It is currently over 2,300 acres in size and ... The 36 Pit Fire was calm Monday night due to ... establishing an anchor point and beginning to construct a fireline ... The following resources are working on the fire: , 7 ...
(Date:9/16/2014)... same viruses that make us sick can take up ... a sneeze, cough or other troublesome symptom, according to ... St. Louis. , On average, healthy individuals carry ... researchers report online in BioMed Central Biology . ... the diversity of viruses in healthy people. , ...
(Date:9/16/2014)... for the dinosaurs 66 million years ago decimated the ... extent than their deciduous peers, according to a study ... the journal PLOS Biology . , Applying ... fossilized leaves of angiosperms flowering plants excluding ... ecology of a diverse plant community thriving during a ...
Breaking Biology News(10 mins):Healthy humans make nice homes for viruses 2Healthy humans make nice homes for viruses 3Meteorite that doomed dinosaurs remade forests 2Meteorite that doomed dinosaurs remade forests 3Meteorite that doomed dinosaurs remade forests 4
... percent as compared to last year,s record size. According to measurements ... 27.7 million tonnes, compared to the 2006 record ozone loss of ... area and the depth of the ozone hole. The area of ... 220 Dobson Units is 24.7 million sq km, roughly the ...
... vaccine delivered through painless microneedles in patches applied ... to delivery through hypodermic needles, according to researchers ... Technology. Using new grants from the National Institutes ... five years, researchers from the two institutions plan ...
... help may be on the way for beleaguered growers ... Many varieties of the widely grown bottlegourd (Lagenaria siceraria) ... (ZYMV), a scourge of commercial cucurbits that includes pumpkins, ... ZYMV infects cucurbits throughout North America and in other ...
Cached Biology News:2007 ozone hole 'smaller than usual' 22007 ozone hole 'smaller than usual' 3Flu vaccine in painless skin patches under development at Emory, Georgia Tech with NIH grants 2Battling virus disease of watermelon with bottlegourds 2
HOXC11 Antibody...
HOXC11 Antibody...
PPOX Immunogen: PPOX (AAH02357, 378 a.a. ~ 478 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rabbit anti MMP-13, Hinge Region MMP-13 Hinge Region...
Biology Products: